PharmaDrug teams up with leading DMT researcher Jimo Borjigin at the University of Michigan in new study collaboration
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) said Tuesday it is starting DMT studies through a new collaboration with the University of Michigan.
The Toronto-based pharmaceutical company is teaming up with the university’s Dr Jimo Borjigin to study the potential role of DMT, or N, N-dimethyltryptamine, in normal, diseased and altered states of consciousness in a newly-created animal model.
Borjigin has been studying DMT since 2012 and published seminal research, including the discovery of DMT production in the pineal gland of live rats and comparable levels of DMT to common neurotransmitters.
READ: PharmaDrug subsidiary adds drug repurposement expert Moshe Rogosnitzky to its scientific and clinical advisory board
PharmaDrug told shareholders that Borjigin’s work on DMT “continues to evolve and leads to new discoveries of potential functions and understandings of DMT that can be translatable and clinically relevant.”
The partnership is hoping to develop novel therapeutic strategies of DMT for clinical unmet needs that are not currently addressed by DMT, PharmaDrug said in a statement.
“We are excited to work with Dr Borjigin, a prolific DMT researcher, in advancing her pioneering initiatives that seeks to unlock the potential of DMT,” said Daniel Cohen, CEO of PharmaDrug in a statement.
“Our research collaboration with the University of Michigan and its commitment on consciousness science is essential to our psychedelic pharmaceutical strategy of creating a unique portfolio of DMT therapies targeting rare disorders while also focusing on foundational research with DMT to explore and evaluate its therapeutic potential across all physiological areas of the human body.”
Borjigin said she was “pleased” to work with PharmaDrug on novel DMT research.
“I have a long history in studying DMT and I have dedicated my research in understanding how the brain functions and its effects on the heart in normal and abnormal states that can translate to relevant clinical uses,” she told investors.
PharmaDrug is hoping to develop novel uses for DMT and broaden its intellectual property portfolio by creating unique DMT formulations.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/943995/pharmadrug-teams-up-with-leading-dmt-researcher-jimo-borjigin-at-the-university-of-michigan-in-new-study-collaboration-943995.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper -
Bioavailable Copper
destroys
pathogens and gives you more
energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans
out
toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification,
mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter
radiation by 96%! (See Video)
Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.
| Online: | |
| Visits: | 1,219,945,323 |
| Stories: | 7,436,456 |
Whistler Blowers, Insiders
 God's Word - 2 Corinthians Chapter 10 (Jeff Osburn) |
